相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。No One Stays Just on Blockers Forever: Clinicians' Divergent Views and Practices Regarding Puberty Suppression for Nonbinary Young People
Lauren Notini et al.
JOURNAL OF ADOLESCENT HEALTH (2021)
Long-term Puberty Suppression for a Nonbinary Teenager
Ken C. Pang et al.
PEDIATRICS (2020)
Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
Carlotta Cocchetti et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Forever young? The ethics of ongoing puberty suppression for non-binary adults
Lauren Notini et al.
JOURNAL OF MEDICAL ETHICS (2020)
Non-Binary and Binary Gender Identity in Australian Trans and Gender Diverse Individuals
Ada S. Cheung et al.
ARCHIVES OF SEXUAL BEHAVIOR (2020)
Youths with a non-binary gender identity: a review of their sociodemographic and clinical profile
Denise Chew et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Gender diversity and non-binary presentations in young people attending the United Kingdom's National Gender Identity Development Service
Jos Twist et al.
CLINICAL CHILD PSYCHOLOGY AND PSYCHIATRY (2019)
Gender dysphoria: puberty blockers and loss of bone mineral density
Grant Ferguson et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Health Needs of Trans and Gender Diverse Adults in Australia: A Qualitative Analysis of a National Community Survey
Sav Zwickl et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
A comparison of mental health symptomatology and levels of social support in young treatment seeking transgender individuals who identify as binary and non-binary
Nat Thorne et al.
INTERNATIONAL JOURNAL OF TRANSGENDERISM (2019)
Australian standards of care and treatment guidelines for transgender and gender diverse children and adolescents
Michelle M. Telfer et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review
Denise Chew et al.
PEDIATRICS (2018)
Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis
Zhenlang Guo et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Healthcare Experiences Among Young Adults Who Identify as Genderqueer or Nonbinary
James E. Lykens et al.
LGBT HEALTH (2018)
Health and Well-Being of Cisgender, Transgender and Non-Binary Young People
Marta Evelia Aparicio-Garcia et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Non-binary youth: Access to gender-affirming primary health care
Beth A. Clark et al.
INTERNATIONAL JOURNAL OF TRANSGENDERISM (2018)
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline
Wylie C. Hembree et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Association Between Linear Growth and Bone Accrual in a Diverse Cohort of Children and Adolescents
Shana E. McCormack et al.
JAMA PEDIATRICS (2017)
Puberty suppression in transgender children and adolescents
Simone Mahfouda et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents
Mariska C. Vlot et al.
BONE (2017)
Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders
Amanda Crider et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study
L. -M. Sun et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2016)
Effect of selective estrogen receptor modulators on metabolic homeostasis
Beibei Xu et al.
BIOCHIMIE (2016)
Mental health and gender dysphoria: A review of the literature
Cecilia Dhejne et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2016)
Selective estrogen receptor modulators (SERMs): A review of clinical data
Sebastian Mirkin et al.
MATURITAS (2015)
Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
L-M Sun et al.
BRITISH JOURNAL OF CANCER (2014)
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Philipp Y. Maximov et al.
CURRENT CLINICAL PHARMACOLOGY (2013)
The Endocrinologist's Office-Puberty Suppression: Saving Children from a Natural Disaster?
Sahar Sadjadi
JOURNAL OF MEDICAL HUMANITIES (2013)
The evolution of selective estrogen receptor modulators in osteoporosis therapy
P. Hadji
CLIMACTERIC (2012)
The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty
Hong K. Park et al.
CLINICAL ENDOCRINOLOGY (2012)
Selective estrogen receptor modulators as brain therapeutic agents
Maria Angeles Arevalo et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Lasofoxifene and Cardiovascular Events in Postmenopausal Women With Osteoporosis Five-Year Results From the Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) Trial
Kristine Ensrud et al.
CIRCULATION (2010)
Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial
Didy E. Jacobsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Peak Bone Mass From Longitudinal Data: Implications for the Prevalence, Pathophysiology, and Diagnosis of Osteoporosis
Claudie Berger et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Tamoxifen as First-line Treatment in a Premenarchal Girl with Juvenile Breast Hypertrophy
Korcan Demir et al.
Journal of Pediatric and Adolescent Gynecology (2010)
Lasofoxifene in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tamoxifen Treatment and Risk of Deep Venous Thrombosis and Pulmonary Embolism
Rohini K. Hernandez et al.
CANCER (2009)
The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia
Elena Tsourdi et al.
FERTILITY AND STERILITY (2009)
Effects of raloxifene and hormone replacement therapy on forearm skin elasticity in postmenopausal women
H. Sumino et al.
MATURITAS (2009)
Low serum testosterone and mortality in older men
Gail A. Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Male hypogonadism: The unrecognized cardiovascular risk factor
Matthew Potenza et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Tamoxifen Use and Osteoporotic Fracture Risk: A Population-Based Analysis
Andrew L. Cooke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of raloxifene therapy on venous thromboembolism in postmenopausal women
Jurga Adomaityte et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice
Cedric Le May et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene
Michael R. McClung et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2006)
Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status
L Vehmanen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women
CM Francucci et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Estrogen controls lipolysis by up-regulating α2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor α.: Implications for the female fat distribution
SB Pedersen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Management of physiological gynaecomastia with tamoxifen
HN Khan et al.
BREAST (2004)
Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy
A Sverrisdóttir et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: A randomized controlled trial
MR Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy - A clinical review
MPV Gomes et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
分享论文
